XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENTS
6 Months Ended
Dec. 31, 2021
INVESTMENTS [Abstract]  
INVESTMENTS
NOTE 4 – INVESTMENTS
 
The following table summarizes the composition of the Company’s equity method investments with fair value option election and other equity securities at fair value as of December 31, 2021 (successor basis):
 
Asset Type
 
Fair Value
December 31, 2021
 
Publicly Traded Companies
 
$
1,164
 
Promissory Note
    3,014,838  
Non Traded Companies
   
21,344,900
 
Non Traded Company (Equity method investment with fair value option election)
   
3,010,784
 
LP Interests
   
292,830
 
LP Interests (Equity method investment with fair value option election)
   
35,645,406
 
Investment Trust
   
39,776
 
Total
 
$
63,349,698
 

The following table summarizes the composition of the Company’s equity method investments with fair value option election and other equity securities at fair value as of June 30, 2021 (successor basis):
 
Asset Type
 
Fair Value
June 30, 2021
 
Publicly Traded Companies
 
$
169,200
 
Non Traded Companies
   
29,426,441
 
Non Traded Company (Equity method investment with fair value option election)
    2,867,911  
LP Interests
   
288,494
 
LP Interests (Equity method investment with fair value option election)
    37,722,483  
Investment Trust
   
34,714
 
Total
 
$
70,509,243
 

The Company’s above total investments at fair value are disclosed in two separate lines as investments and unconsolidated investments (non-securities) in the consolidated balance sheet as of December 31, and June 30, 2021.

The following table presents fair value measurements of the Company’s investments as of December 31, 2021, according to the fair value hierarchy that is described in our annual report on Form 10-K (successor basis):

Asset Type
 
Total
   
Level I
   
Level II
   
Level III
 
Publicly Traded Companies
 
$
1,164
   
$
1,164
   
$
-
   
$
-
 
Non Traded Companies
   
24,355,684
     
-
     
-
     
24,355,684
 
LP Interests
   
35,938,236
     
-
     
-
     
35,938,236
 
Promissory Note     3,014,838       -       -       3,014,838  
Investment Trust
   
39,776
     
-
     
-
     
39,776
 

 
$
63,349,698
   
$
1,164
   
$
-
   
$
63,348,534
 

Liability
                               
Securities Sold, Not Yet Purchased 
  $ 7,837,286     $ 7,837,286     $ -     $ -  


The following table presents fair value measurements of the Company’s investments as of June 30, 2021, according to the fair value hierarchy that is described in our annual report on Form 10-K (successor basis):
 
Asset Type
 
Total
   
Level I
   
Level II
   
Level III
 
Publicly Traded Companies
 
$
169,200
   
$
169,200
   
$
-
   
$
-
 
Non Traded Companies
   
32,294,352
     
-
     
-
     
32,294,352
 
LP Interests
   
38,010,977
     
-
     
-
     
38,010,977
 
Investment Trust
   
34,714
     
-
     
-
     
34,714
 
Total
 
$
70,509,243
   
$
169,200
   
$
-
   
$
70,340,043
 
 
The following is a reconciliation of the beginning and ending balances for investments measured at fair value on a recurring basis using significant unobservable inputs (Level III of the fair value hierarchy) for the six months ended December 31, 2021 (successor basis):
 
Balance at July 1, 2021
 
$
70,340,043
 
Purchases of investments
   
3,232,548
 
Transfers to Level I
   
(230,160
)
Proceeds from sales, net
    (14,307,919 )
Return of capital distributions
   
(4,204,209
)
Net realized gain
   
3,656,387
 
Net unrealized gains
   
4,861,844
 
Ending balance at December 31, 2021
 
$
63,348,534
 

The transfer of $230,160 of investments from Level III to Level I category during the six months ended December 31, 2021 resulted from one of the Company’s investments converting from a non-traded REIT to publicly traded REIT. Transfers are assumed to have occurred at the beginning of the period.
 
For the six months ended December 31, 2021, changes in unrealized gains, net included in earnings relating to Level III investments still held at December 31, 2021 were $6,731,322.

The following is a reconciliation of the beginning and ending balances for investments measured at fair value on a recurring basis using significant unobservable inputs (Level III of the fair value hierarchy) for the six months ended December 31, 2020 (predecessor basis):
 
Balance at July 1, 2020
 
$
86,460,491
 
Purchases of investments
   
13,448,477
 
Transfers to Level I
   
(1,900,470
)
Consolidation of the Operating Partnership
   
(8,027,584
)
Proceeds from sales, net
   
(1,011,748
)
Return of capital
   
(11,486,835
)
Net realized gains
   
30,050
 
Net unrealized losses
   
(8,634,492
)
Ending balance at December 31, 2020
 
$
68,877,889
 
 
The transfer of $1,900,470 of investments from Level III to Level I category during the six months ended December 31, 2020 resulted from one of the Company’s investments converting from a non-traded REIT to publicly traded REIT. Transfers are assumed to have occurred at the beginning of the period.
 
For the six months ended December 31, 2020, changes in unrealized losses, net included in earnings relating to Level III investments still held at December 31, 2020 were $1,836,915.

The following table shows quantitative information about significant unobservable inputs related to the Level III fair value measurements used at December 31, 2021 (successor basis):
 
Asset Type
 
Fair Value
 
Primary Valuation
Techniques
 
Unobservable Inputs Used
 
Range
   
Weighted
Average
 
                         
Non Traded Company
 
$
3,010,784
 
Direct Capitalization Method
 
Capitalization rate
 
7.37%

     

               
 
Liquidity discount
  33.0%
 
 
Non Traded Companies
   
21,677
 
Estimated Liquidation Value
 
Sponsor provided value
           
                           
Liquidity discount
 
82.0%

 

 
                   
SEC filings
           
Non Traded Companies
   
21,323,223
 
Market Activity
 
Secondary market industry publication
           
                           
Contracted sale of the property
           
                           
LP Interests
   
17,108,315
 
Direct Capitalization Method
 
Capitalization rate
 
3.6% - 8.0%

 
4.93%

                           
Liquidity discount
  33.0%
     
LP Interest
   
5,000,000
 
Discounted Cash Flow
 
Discount rate
 
9.0%

     
LP Interests
   
8,534,000
 
Estimated Liquidation Value
 
Sponsor provided value
           
                           
Contracted sale of the property
           
LP Interest
    5,295,921  
Market Activity
 
Contracted sale of the property
           
                           
Investment Trust
   
39,776
 
Direct Capitalization Method
 
Capitalization rate
 
6.0%

     
                           
Liquidity discount
 
33.0%

     
                           
Promissory Note
    3,014,838   Estimated Liquidation Value  
Forbearance agreement
           
                           
   
$
63,348,534
                   
 
The following table shows quantitative information about significant unobservable inputs related to the Level III fair value measurements used at June 30, 2021 (successor basis):

Asset Type
 
Fair Value
 
Primary Valuation
Techniques
 
Unobservable Inputs Used
 
Range
   
Wt.
Average
 
                         
Non Traded Company
 
$
2,867,911
 
Direct Capitalization Method
 
Capitalization rate
 
7.9%

 

 
                                       
Liquidity discount
 
32.0%

 

 
Non Traded Companies
   
66,337
 
Estimated Liquidation Value
 
Sponsor provided value
           
                                       
Liquidity discount
 
2.0% - 67.0%

 
53.6%

                          Bankruptcy filing            
Non Traded Companies
   
29,360,104
 
Market Activity
 
Secondary market industry publication
           
         
  Underlying property sales contract            
                          Acquisition cost            
                           
LP Interests
   
19,717,495
 
Direct Capitalization Method
 
Capitalization rate
 
3.5% - 7.5%

 
5.8%

                                       
Liquidity discount
 
20.0% - 33.0%

 
20.9%

LP Interests
   
11,448,000
 
Discounted Cash Flow
 
Discount rate
 
9.0% - 20.0%

 
13.2%

                                       
Discount term (months)
 
24
       
LP Interests
   
6,845,482
 
Estimated Liquidation Value
 
Sponsor provided value
           
                                       
Underlying property sales contract
           
                                       
Liquidity discount
 
5.0% - 46.19%

 
16.1%

                          Appraisal            
                           
Investment Trust
   
34,714
 
Direct Capitalization Method
 
Capitalization rate
  6.0%
     
                          Liquidity discount   33.0%
     
   
$
70,340,043
                   
 
Impact of COVID-19 Pandemic

The COVID-19 pandemic and related changes in tenant behavior have adversely impacted the fair value of our investments as of December 31, 2021 and June 30, 2021, and the values assigned as of this date may differ materially from the values that we may ultimately realize with respect to our investments. The impact of the COVID-19 pandemic may not yet be fully reflected in the valuation of our investments as our valuations, and particularly valuations of private investments and private companies, are inherently uncertain, may fluctuate over short periods of time and are often based on estimates, comparisons and qualitative evaluations of private information that is often from a time period earlier, generally two to three months, than the quarter for which we are reporting. Additionally, we may not have yet received information or certifications from our portfolio companies that indicate any or the full extent of declining performance or non-compliance with debt covenants, as applicable, as a result of the COVID-19 pandemic. As a result, our valuations at December 31, 2021 and June 30, 2021, may not show the complete or continuing impact of the COVID-19 pandemic and the resulting measures taken in response thereto. Accordingly, we may continue to incur additional net unrealized losses or may incur realized losses subsequent to December 31, 2021, which could have a material adverse effect on our business, financial condition and results of operations.
 
Summarized or Separate Audited Financial Statements for Equity Method Investments (Fair Value Option)
 
Our investments in securities are generally in small and mid-sized companies in a variety of industries. In accordance with Rules 3-09 and 4-08(g) of Regulation S-X, we must determine which of our equity method investments measured at fair value under the Fair Value Option are considered “significant,” if any. Regulation S-X mandates the use of three different tests to determine if any of our investments are considered significant investments: the investment test, the asset test, and the income test. Rule 3-09 of Regulation S-X requires separate audited financial statements for any significant equity method investments in an annual report if any of the three tests exceed 20%. Rule 4-08(g) of Regulation S-X requires summarized financial information in an annual report if any of the three tests exceeds 10%. For interim reporting, under SEC Rule 10-01(b)(1), the investment and income tests prescribed under Rule 3-09 should be applied to all of our equity method investments measured at fair value under the Fair Value Option and if either of the two tests exceed 20%, summarized income statement information of each equity method investee is required to be disclosed separately. The summarized income statement information is not required for any equity method investee that would not be required, pursuant to Rule 13a-13 or 15d-13, to file quarterly financial information with the SEC if it were a registrant.
 
In addition to the SEC rules, ASC 323-10-50-3(c) requires summarized financial statements of its equity method investments, including those reported under the fair value option, if they are material individually or in aggregate. The Company’s equity method investments accounted under the fair value option were material in aggregate as of December 31, 2021. The aggregated summarized financial information of the investees is as follows:
 
Total Assets
 
$
234,277,621
 
Total Liabilities
 
$
151,293,866
 
Total Equities
 
$
82,983,755
 
Total Revenues
 
$
21,707,508
 
Total Expenses
 
$
22,083,535
 
Total Net Loss
 
$
(376,026
)
 
Unconsolidated Significant Subsidiaries

In accordance with SEC Rules 3-09 and 4-08(g) of Regulation S-X, we must determine which of our investments in securities are considered “significant subsidiaries,” if any. Regulation S-X mandates the use of three different tests to determine if any of our controlled investments are significant subsidiaries: the investment test, the asset test, and the income test. Rule 3-09 of Regulation S-X requires separate audited financial statements for any unconsolidated majority-owned subsidiary in an annual report if any of the three tests exceed 20%. Rule 4-08(g) of Regulation S-X requires summarized financial information in an annual report if any of the three tests exceeds 10%.

As of December 31, 2021 and June 30, 2021, none of our investments in securities was considered a significant subsidiary under the SEC rules described above.